The annual ASCO congress in Chicago, a leading event in cancer research, highlighted U.S. breakthroughs in pancreatic cancer treatment as well as the rapid rise of Chinese biotechnology. China and India now compete directly with the United States and Europe in the global pharmaceutical market.